Involvement of Actin Filaments in the Cytotoxic Effect of GD2-Specific Antibodies


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Induction of direct cell death is one of the mechanisms of the antitumor effect of GD2-specific antibodies used for the therapy of high-risk neuroblastoma. The mechanisms of the cytotoxic signal triggered by antibody binding to GD2 ganglioside on the surface of the tumor cell remain insufficiently studied. Using inhibitor analysis we demonstrated that actin microfilaments are involved in the cell death induced by GD2-specific antibodies. Specifically, a strong antagonistic influence of cytochalasin D on the cytotoxic effect induced by GD2-specific antibodies was demonstrated in GD2+ tumor cell lines, which was expressed in at least 20% increase in cell survival and a significant decrease of the fraction of cells with fragmented DNA.

About the authors

I. I. Doronin

M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Real Target Company

Email: khol@mail.ru
Russian Federation, Moscow; Moscow

I. V. Kholodenko

V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: khol@mail.ru
Russian Federation, Moscow

A. A. Zubareva

M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: khol@mail.ru
Russian Federation, Moscow

K. N. Yarygin

V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: khol@mail.ru
Russian Federation, Moscow

S. M. Deev

M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: khol@mail.ru
Russian Federation, Moscow

R. V. Kholodenko

M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Author for correspondence.
Email: khol@mail.ru
Russian Federation, Moscow


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies